Hyperfine (HYPR) Gains from Investment Securities (2025 - 2026)
Hyperfine's (HYPR) quarterly Gains from Investment Securities came in at $241000.0 in Q1 2026, up 114.89% YoY from $112147.8 in Q1 2025, and up 116.46% on a QoQ basis from -$1.5 million in Q4 2025.
Hyperfine (HYPR) Gains from Investment Securities (2025 - 2026) Analysis & Trends
Hyperfine (HYPR) has 2 years of Gains from Investment Securities data on file, last reported at $241000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 114.89% year-over-year to $241000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 163.91% YoY) and the FY2025 annual result came in at -$825000.0, changed N/A from the prior year.
- Gains from Investment Securities grew to $241000.0 in Q1 2026, from -$1.5 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.3 million in Q3 2025 to a low of -$1.6 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Hyperfine | 88.57 Mn | 43.81 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 571,000.00 |
| Jun 30, 2026 | 571,000.00 |
| Mar 31, 2026 | 241,000.00 |
| Mar 31, 2026 | 241,000.00 |
| Dec 31, 2025 | -1.46 Mn |
| Dec 31, 2025 | -1.46 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -46,000.00 |
| Mar 31, 2025 | -1.62 Mn |
| Mar 31, 2025 | -1.62 Mn |